- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04289233
Molecular & Cellular Characterisation of Oral Lichen Planus
April 17, 2024 updated by: University of Birmingham
The principal research objective is to provide enhanced understanding of the cellular and molecular events important in the pathogenesis of Oral Lichen Planus to enable improved diagnosis and development of novel treatments for patients.
Study Overview
Status
Completed
Conditions
Detailed Description
The following questions will also be addressed:
- Are the histological architectural tissue changes that take place in oral lichen planus quantifiable using computer based imaging, graph theory and fractal geometry principles? Quantification of these changes would allow the development of a tool to facilitate the accurate measurement of response to treatment.
- What is the nature of such architectural changes and what are the differences with normal, dysplastic and neoplastic epithelia (the investigators have morphometrical data collected from previous research to allow such comparisons).
- Is it possible to produce evidence-based statistical classification into established diagnostic classes using the proposed methodology? This would contribute towards making histopathological diagnosis more quantitative, reproducible and accurate.
- Is it possible to automate such morphometrical analysis/classification? This would allow large data sets to be screened automatically in a shorter time frame and at lower cost than human based screening.
- Is it possible to determine differences in genetics and gene expression of keratinocytes involved in Oral Lichen Planus compared to those of 'normal' tissue by using biopsy material and an in vitro model of oral lichen planus?
Study Type
Observational
Enrollment (Actual)
70
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Gabriel Landini, PhD
- Phone Number: +44 0121 466 5519
- Email: G.Landini@bham.ac.uk
Study Contact Backup
- Name: Ana Poveda Gallego, Consultant
- Phone Number: +44 0121 466 6670
- Email: p.g.ana@bham.ac.uk
Study Locations
-
-
West Midlands
-
Birmingham, West Midlands, United Kingdom, B5 7EG
- Birmingham Dental Hospital and School of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients registered at Birmingham Dental Hospital and attending a clinic for OLP diagnosis.
Patients will be identified by their normal healthcare consultant and invited to participate.
Informed consent will always be obtained prior to any study related procedures being undertaken.
Description
Inclusion Criteria:
- Patient is 16 years old or over
- Patient is willing and able to provide valid informed consent
- Patient is attending the Oral Lichen Planus clinic and will be having a routine clinical biopsy taken
Exclusion Criteria:
- Patient under 16 years old
- Patient is immunocompromised
- Patients with comorbid disease state e.g. other inflammatory disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Histological architecture
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
Are the histological architectural tissue changes that take place in oral lichen planus quantifiable using computer based imaging, graph theory and fractal geometry principles?
|
Through study completion, (maximum 12 months from the defined end of study)
|
Comparisons with other dysplastic lesions
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
What is the nature of such architectural changes and what are the differences with normal, dysplastic and neoplastic epithelia
|
Through study completion, (maximum 12 months from the defined end of study)
|
Statistical classifications
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
Is it possible to produce evidence-based statistical classification into established diagnostic classes using the proposed methodology
|
Through study completion, (maximum 12 months from the defined end of study)
|
Automation of morphological features
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
Is it possible to automate such morphometrical analysis/classification?
|
Through study completion, (maximum 12 months from the defined end of study)
|
Molecular expression of Oral Lichen Planus markers
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
Is it possible to determine differences in genetics and gene expression of keratinocytes involved in Oral Lichen Planus compared to those of 'normal' tissue by using biopsy material and an in vitro model of oral lichen planus?
|
Through study completion, (maximum 12 months from the defined end of study)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gabriel Landini, Phd, University of Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 26, 2016
Primary Completion (Actual)
February 26, 2023
Study Completion (Actual)
February 26, 2023
Study Registration Dates
First Submitted
January 31, 2020
First Submitted That Met QC Criteria
February 27, 2020
First Posted (Actual)
February 28, 2020
Study Record Updates
Last Update Posted (Actual)
April 18, 2024
Last Update Submitted That Met QC Criteria
April 17, 2024
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RG_15-112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Lichen Planus
-
Cairo UniversityUnknownPatients With Oral Lichen PlanusEgypt
-
Alexandria UniversityCompletedEvaluation of Diode Laser and Topical Steroid Therapy in the Treatment of Erosive Oral Lichen PlanusErosive Oral Lichen PlanusEgypt
-
Mashhad University of Medical SciencesUnknownTherapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen PlanusErosive Oral Lichen Planus | Atrophic Oral Lichen PlanusIran, Islamic Republic of
-
Pia Lopez JornetCompletedOral Lichen Planus | Oral Lichen Planus Related StressSpain
-
Panineeya Mahavidyalaya Institute of Dental Sciences...CompletedOral Lichen Planus Related StressIndia
-
Cairo UniversityCompletedErosive Oral Lichen PlanusEgypt
-
University of North Carolina, Chapel HillEli Lilly and CompanyRecruitingLichen Planus, Oral | Oral Lichen Planus | Lichen Planus, MucosalUnited States
-
Nourhan M.AlyAlexandria UniversityCompleted
-
Mashhad University of Medical SciencesCompleted